Reaction

Medical Device Site Cellulitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 57 reports · 2 co-occurring drugs

As of the last recalculation, Medical Device Site Cellulitis appears in 57 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is INSULIN GLULISINE (PRR 545.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Insulin Glulisine12545.6546.2
Insulin Degludec10188.5188.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.